Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Scienture Holdings Inc
SCNX
Healthcare
Drug Manufacturers - Major
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases...
. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SCNX)
New Post
View:
Posts & Comments
Threaded Posts
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 18, 2025 8:34am
Buy buddy buy.
Otherwise you guys out there will be left behind by the markets and
(216)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 06, 2025 8:56am
Buy buddy buy because it's taking off this morning.
Otherwise you guys will be missing out on this stock today and making big profits also good luck to all of you guys out there and to buy low and sell high is the wayto play it
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 26, 2024 9:07am
MEDS...NR & Halt resumed
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million 2024-07-26 05:01 ET - News Release Scienture, Inc., a
...more
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Mar 06, 2024 9:20am
MEDS....early a.m runner on NR
TRxADE Health, Inc. Announces Special Cash Dividend 2024-03-06 05:05 ET - News Release TAMPA, FL, March 06, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH Inc. (Nasdaq
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 24, 2023 8:05am
New Press Release - Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand
TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc. (NASDAQ: MEDS) and is gearing up to revolutionize the snack industry. The Company has unveiled its intent to introduce pulse-based twisted protein snacks through...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 22, 2023 8:05am
New Press Release - Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.
Combinedcompany,focusedonsustainable,equitablefoodportfolio,expectedtomore readily penetrate new markets and accelerate transition to animal-free brands Oncecomplete,transactionimmediatelyaccretivetoSuperlatus revenues. TAMPA, FL, Aug. 22, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 14, 2023 10:25am
New Press Release - TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing
TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today announced that it has filed for an extension to file its Quarterly Report on Form 10-Q for Q2 pursuant to a Form 12b-25 filed with the SEC. The Company is...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 03, 2023 9:05am
New Press Release - Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team
Forbes Fisher Appointed as Chief Operating Officer.Dr. Eugenio Bortone Appointed as Chief Innovation & Food Technology Officer. TAMPA, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc (NASDAQ: MEDS), parent company of pharmaceutical B2B exchange platform, which recently merged with...
read article.
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 2:32pm
MEDS...vols have decreased dramatically
just sayin
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 2:30pm
MEDS....might be done...might be a shake out before
"power hour" Place ur bets Me ...no position
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 2:04pm
MEDS .... at support at $10.08.....better start a rally...
right now or watch out below....next support close to $9 Cheers
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 10:26am
MEDS.....Nice scalp !!!
Out at $12.35....Cheers !
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 10:14am
MEDS ....Ka F'king Booooooom !!!!
Halted.....last at $11.65 up $4.94 Cheers to the Bulls !!!!
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 9:51am
WRNT .....surprise surprise....Boom into gap!!
Sold to America !!!! Cheers !
(107)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 02, 2023 9:27am
MEDS....early a.m runner on NR
On watch TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc. (yahoo.com)
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Developing a sizeable copper resource with a highly prospective exploration asset in Peru
Identifying new compelling targets on extensive and highly prospective land position